Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Gastroenterology

Can CSID Carriers (Heterozygous) Experience Symptoms?

At a Glance

Some people with one disease-causing SI gene variant can develop partial sucrase-isomaltase deficiency and symptoms such as diarrhea, gas, bloating, or loose stools, but carrier status alone does not prove CSID; other causes and supervised testing or treatment trials matter.

Yes, it is possible. While Congenital Sucrase-Isomaltase Deficiency (CSID) is traditionally considered a condition that requires two mutated genes to cause illness, modern research indicates that some people with only one mutated gene (a state called being heterozygous or a carrier) can experience Irritable Bowel Syndrome (IBS)-like symptoms [1][2].

If your doctor has been hesitant to attribute your chronic diarrhea, gas, or bloating to a single genetic variant, it is because carrier status alone does not automatically diagnose you with a symptomatic enzyme deficiency [3]. However, emerging evidence supports that a single variant can contribute to real digestive distress in some individuals, and your symptoms deserve a thorough, collaborative evaluation [4].

Understanding Your Genetics

You receive two copies of the SI gene—one from each parent. This gene provides instructions for sucrase-isomaltase, an enzyme necessary to break down certain sugars (like sucrose) and starches in your small intestine.

  • Biallelic Disease (Classic CSID): You have pathogenic (disease-causing) variants in both copies of the SI gene. This can be two identical variants (homozygous) or two different variants (compound heterozygous) [5]. This usually results in a severe lack of enzyme activity.
  • Heterozygous (Carrier): You have a variant in only one copy of the SI gene.

Because one gene is theoretically normal, it was traditionally believed carriers produced enough enzyme to prevent symptoms. However, it is important to know exactly which variant you have. Some are known to be pathogenic, while others are “variants of uncertain significance” (VUS) [4]. Additionally, standard genetic testing sometimes misses a second, harder-to-detect mutation [4].

Why Might a Single Variant Cause Symptoms?

When you have a single pathogenic SI variant, you may experience a partial enzyme deficiency [6]. While you likely have more enzyme activity than someone with classic CSID, it might not be enough to comfortably digest large carbohydrate meals.

Research suggests a few reasons why some carriers develop symptoms:

  • Reduced Enzyme Function: Some variants produce an enzyme that is simply less efficient at breaking down sugars [7].
  • Interference: In laboratory models, some specific mutated enzymes can interact with and “trap” the normal enzymes, preventing them from reaching the surface of your intestine where they do their job [8].
  • Fermentation: Unabsorbed sugars travel to your large intestine, where bacteria ferment them. This causes the gas, bloating, and diarrhea that can overlap with IBS [2].

What the Clinical Research Shows

The idea that carriers can be symptomatic is increasingly recognized, though the severity varies widely from person to person [3].

  • Family Studies: In one specific study of a family with a known SI mutation, 44% of the heterozygous carriers reported symptoms like abdominal pain, gas, and foul-smelling stools [1].
  • Link to IBS: Studies have found that certain single SI variants are more common in people diagnosed with diarrhea-predominant IBS than in healthy individuals [2].
  • Pediatric Findings: Among children evaluated for chronic, unexplained loose stools, single reduced-function SI variants were more prevalent, and those carrying the variants often had looser, more frequent stools [9].

It is important to note that these studies show an association in specific groups, rather than proving that every carrier in the general population will have symptoms. Some carriers see improvement when treated with enzyme replacement therapy (sacrosidase) or dietary changes, but responses vary [10].

Next Steps and Safety Evaluation

Having a heterozygous genetic result gives you a clue, but it is not a complete diagnosis. It is crucial not to assume your single variant is the sole cause of your symptoms without looking at the bigger picture.

Rule Out Other Causes and Alarm Symptoms
A carrier result should not stop your doctor from evaluating you for other conditions that cause similar symptoms, such as celiac disease, inflammatory bowel disease (IBD), microscopic colitis, or small intestinal bacterial overgrowth (SIBO) [11][12].

Seek prompt medical attention if you experience alarm symptoms, which are not typical of SI deficiency:

  • Blood in your stool or black stools
  • Unintentional weight loss
  • Fever or anemia
  • Diarrhea that wakes you up at night
  • Severe or rapidly worsening pain

Diagnostic Testing and Treatment Trials
Confirming if your specific variant is reducing your digestive capacity requires specialized guidance.

  • Testing: Your doctor might discuss a duodenal biopsy to directly measure enzyme levels, though this is invasive and enzyme activity can be patchy. Alternatively, sucrose breath tests are non-invasive but have limitations, as conditions like SIBO can confound the results [4][11].
  • Supervised Trials: Often, a practical step is a time-limited, structured trial of a low-sucrose diet or enzyme replacement therapy (sacrosidase) [12]. Because these changes can affect your overall nutrition, this should ideally be supervised by a registered dietitian to ensure you are not unnecessarily restricting healthy foods. Keep in mind that sacrosidase targets sucrase, not all starches, and feeling better on a diet does not definitively prove the genetic variant is the sole cause.

Common questions in this guide

Can a person with one SI gene variant have digestive symptoms?
Yes. Some people with one disease-causing SI gene variant may have partial sucrase-isomaltase deficiency and symptoms such as diarrhea, gas, bloating, abdominal pain, or loose stools. Not every carrier has symptoms, and a genetic result alone does not prove that the variant is the cause.
What does heterozygous mean in CSID?
Heterozygous means that one of your two SI gene copies has a variant and the other copy does not. Classic CSID usually involves disease-causing variants in both copies, but the exact variant matters because some reduce enzyme function more than others. A variant of uncertain significance may not explain symptoms.
Could genetic testing miss a second SI gene variant?
Yes, some standard genetic tests may miss a harder-to-detect change in the second SI gene copy. Your clinician can review the test method and the variant classification to decide whether additional testing is appropriate. Two disease-causing variants would support classic CSID more strongly than one.
How is partial sucrase-isomaltase deficiency tested?
A clinician may consider a sucrose breath test or a biopsy from the duodenum that measures enzyme activity. Breath tests are noninvasive but can be affected by conditions such as small intestinal bacterial overgrowth, while biopsy is invasive and enzyme activity can vary across the intestine. Test results should be interpreted with symptoms, genetics, and evaluation for other causes.
What treatments can help a symptomatic CSID carrier?
A clinician may suggest a time-limited, supervised trial of reducing sucrose in the diet or using sacrosidase, an enzyme replacement medicine. Sacrosidase helps digest sucrose but does not replace every enzyme needed for starch digestion. A registered dietitian can help prevent unnecessary food restriction, and improvement does not prove the SI variant is the only cause.
Which warning signs mean chronic diarrhea needs prompt medical care?
Seek prompt medical attention for blood or black stools, unintentional weight loss, fever, anemia, diarrhea that wakes you at night, or severe or rapidly worsening pain. These warning signs are not typical of SI deficiency and need evaluation for other causes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What exact SI variant do I have, and is it classified as pathogenic, likely pathogenic, or a variant of uncertain significance (VUS)?
  2. 2.Given that I have a single SI gene mutation, could this explain my symptoms, or could my genetic test have missed a second variant?
  3. 3.What other causes of chronic diarrhea, such as celiac disease or small intestinal bacterial overgrowth (SIBO), have we evaluated?
  4. 4.If we pursue a duodenal biopsy or a breath test, what are the limitations of those tests for diagnosing a partial enzyme deficiency?
  5. 5.How would we structure a time-limited trial of a sucrose-restricted diet or enzyme replacement to measure if it actually helps?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    Congenital Sucrase-Isomaltase Deficiency: Same Mutation with Different Clinical Presentations.

    İryancı Fİ, Güven B, Çakır M

    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2024; (35(4)):343-349 doi:10.5152/tjg.2024.23250.

    PMID: 39128102
  2. 2

    Functional variants in the sucrase-isomaltase gene associate with increased risk of irritable bowel syndrome.

    Henström M, Diekmann L, Bonfiglio F, et al.

    Gut 2018; (67(2)):263-270 doi:10.1136/gutjnl-2016-312456.

    PMID: 27872184
  3. 3

    A call for caution in expanding the mutational spectrum of SI gene deficiency.

    Spurná Z, Fišer M, Macek M, Schwarz M

    Scandinavian journal of gastroenterology 2026; (61(9)):916-921 doi:10.1080/00365521.2026.2681103.

    PMID: 42223142
  4. 4

    Genetic and acquired sucrase-isomaltase deficiency: A clinical review.

    Danialifar TF, Chumpitazi BP, Mehta DI, Di Lorenzo C

    Journal of pediatric gastroenterology and nutrition 2024; (78(4)):774-782 doi:10.1002/jpn3.12151.

    PMID: 38327254
  5. 5

    Congenital Sucrase-isomaltase Deficiency: A Novel Compound Heterozygous Mutation Causing Aberrant Protein Localization.

    Haberman Y, Di Segni A, Loberman-Nachum N, et al.

    Journal of pediatric gastroenterology and nutrition 2017; (64(5)):770-776 doi:10.1097/MPG.0000000000001424.

    PMID: 27749612
  6. 6

    Molecular pathogenicity of novel sucrase-isomaltase mutations found in congenital sucrase-isomaltase deficiency patients.

    Gericke B, Amiri M, Scott CR, Naim HY

    Biochimica et biophysica acta. Molecular basis of disease 2017; (1863(3)):817-826 doi:10.1016/j.bbadis.2016.12.017.

    PMID: 28062276
  7. 7

    Differential Effects of Sucrase-Isomaltase Mutants on Its Trafficking and Function in Irritable Bowel Syndrome: Similarities to Congenital Sucrase-Isomaltase Deficiency.

    Husein DM, Rizk S, Naim HY

    Nutrients 2020; (13(1)) doi:10.3390/nu13010009.

    PMID: 33375084
  8. 8

    Severe pathogenic variants of intestinal sucrase-isomaltase interact avidly with the wild type enzyme and negatively impact its function and trafficking.

    Husein DM, Rizk S, Hoter A, et al.

    Biochimica et biophysica acta. Molecular basis of disease 2022; (1868(11)):166523 doi:10.1016/j.bbadis.2022.166523.

    PMID: 35985447
  9. 9

    Hypomorphic SI genetic variants are associated with childhood chronic loose stools.

    Chumpitazi BP, Lewis J, Cooper D, et al.

    PloS one 2020; (15(5)):e0231891 doi:10.1371/journal.pone.0231891.

    PMID: 32433684
  10. 10

    Congenital sucrase-isomaltase deficiency in Türkiye; a single center experience.

    Barut D, Kıran Taşcı E, Kunay B, et al.

    Scandinavian journal of gastroenterology 2024; (59(6)):647-651 doi:10.1080/00365521.2024.2324961.

    PMID: 38459691
  11. 11

    Diagnosing Congenital Sucrase-Isomaltase Deficiency in Children: An Algorithm Using Combined Breath Testing.

    Hoskins BJ, Freeman J, Kutty S, et al.

    Pediatric gastroenterology, hepatology & nutrition 2026; (29(2)):120-130 doi:10.5223/pghn.2026.29.2.120.

    PMID: 41877710
  12. 12

    Demystifying Carbohydrate Maldigestion: A Clinical Review.

    Cash BD, Patel D, Scarlata K

    The American journal of gastroenterology 2025; (120(4S)):1-11 doi:10.14309/ajg.0000000000003374.

    PMID: 40249016

This page is for informational purposes only and does not constitute medical advice. A gastroenterology or genetics clinician and a registered dietitian can help interpret your SI result, evaluate other causes, and plan testing or treatment.

Get notified when new evidence is published on Congenital sucrase-isomaltase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.